Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)

generic drugs

As Valeant Ups Salix Buyout, Will Endo Come Back?

Monday morning, Salix Pharmaceuticals Ltd. (NASDAQ: SLXP) and Valeant Pharmaceuticals International Inc. (NYSE: VRX) both announced that they had entered into an agreement on their plan to merge based on ...
Read Full Story »
179378515

5 Highly Unusual Stock Moves of the Past Week

The bull market may have seen an interruption this past week, but stocks are still very close to all-time highs and this bull market is now six years old. It ...
Read Full Story »
Sell Button

Insider Selling Picks Up as Market Volatility Starts to Jump

As we expected, with the earnings reporting season all but over for this quarter, more and more windows appear to be opening for insiders looking to sell positions. Combine that ...
Read Full Story »
payoff

Salix Now Has 2 Merger Dance Partners

The merger situation around Salix Pharmaceuticals Ltd. (NASDAQ: SLXP) just became much more complicated. Endo International PLC (NASDAQ: ENDP) has made a bid for Salix in a private letter sent to ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Comcast, Groupon, HCA, J.P. Morgan, JetBlue, NetApp, Verifone and More

Stocks were indicated lower on Wednesday morning, but that is after new highs were seen. One thing has been proven over and over in this bull market: investors will buy ...
Read Full Story »
145922793

Analyst’s Top 4 Specialty Pharmaceutical Stocks to Buy Before Earnings

While most of the top stocks in the S&P 500 are winding up the third-quarter reporting season, the specialty pharmaceutical stocks are ready to come from the on-deck circle and ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Apple, Cliffs, Cree, Salesforce.com, SunPower and More

Stocks were trading up handily ahead of the key unemployment and payrolls report on Friday morning. What is amazing is that investors keep proving over and over that they will buy oversold or overlooked ...
Read Full Story »
biotech

3 Likely Biotech Buyout Candidates

The pharmaceutical business is a difficult one, because patent expiration and competition are always omnipresent factors. Obviously major companies like to keep large research and development projects moving at full ...
Read Full Story »
Tax

Is Treasury Plan for Tax Inversion REALLY Trouble for Merger Stocks?

The U.S. Treasury has finally made its proposed effort to deal with the waves of corporate tax inversions that have created such a stir of late. The move is also ...
Read Full Story »
Monkey evil

Top Analyst Upgrades and Downgrades: Dollar Stores, Lululemon, Netflix, Sprint, T-Mobile, Alibaba and More

Stocks were looking for direction on Friday morning and the markets may finally be poised for a down week. Still, investors seem to be looking for opportunities with overlooked stocks or ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Alcoa, Cigna, Intel, Molina, Teva, UnitedHealth and More

Stocks were looking to take a breather on Friday morning, but investors are still actively looking for ideas for a bull market or a stock picker's markets. 24/7 Wall St. ...
Read Full Story »
145922793

Five Top Health Care Names From RBC to Buy Now

The intense analysis of quantitative managers may seem like drudgery, but it can turn up absolute gems for investors looking for solid long ideas. In fact, firms like RBC use ...
Read Full Story »
DNA

Ten Top Biotech Merger and Partnership Candidates

One of the ways the big pharmaceutical and biotechnology firms grow their business is through partnerships and acquisitions. That was never more in focus than Thursday when Pfizer lost its ...
Read Full Story »

11 Unusual After-Hours Stocks on the Move (MDRX, WIFI, GNOM, DDS, MBI, MRX, MM, MNST, NQ, SLXP, SPWR)

24/7 Wall St. is tracking eleven key stocks on the move in the after-hours session. Most are of course on earnings, but this shows the move and a brief comment ...
Read Full Story »

FDA Complete Response Letter Takes a Big Bite Out of Hope (SLXP, PGNX)

The U.S. Food & Drug Administration has sent Salix Pharmaceuticals Ltd. (NASDAQ: SLXP) and Progenics Pharmaceuticals Inc. (NASDAQ: PGNX) a Complete Response Letter (CRL) regarding the drug Relistor's supplemental new drug application. ...
Read Full Story »